公开(公告)号：US20190275008A1

公开(公告)日：2019-09-12

申请号：US16347903

申请日：2017-11-03

Applicant: AMGEN INC.

Inventor： Matthew BROWN ,  Ning CHEN ,  Xiaoqi CHEN ,  Yinhong CHEN ,  Alan C. CHENG ,  Richard V. CONNORS ,  Jeffrey DEIGNAN ,  Paul John DRANSFIELD ,  Xiaohui DU ,  Zice FU ,  James S. HARVEY ,  Julie Anne HEATH ,  Lars V. HEUMANN ,  Jonathan HOUZE ,  Frank KAYSER ,  Aarif Yusuf KHAKOO ,  David j. KOPECKY ,  Su-Jen LAI ,  Zhihua MA ,  Julio C. MEDINA ,  Jeffrey T. MIHALIC ,  Steven H. OLSON ,  Vatee PATTAROPONG ,  Gayathri SWAMINATH ,  Xiaodong WANG ,  Malgorzata WANSKA ,  Wen-Chen YEH

IPC: A61K31/4196 ,  C07D405/14 ,  C07D405/04 ,  A61K31/506 ,  C07D405/12 ,  C07D471/04 ,  A61K31/437 ,  C07F7/08 ,  A61K31/4439 ,  A61K31/501 ,  C07D413/12 ,  A61K31/421 ,  C07D239/26 ,  C07D403/12

Abstract: Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula (I) and Formula (II) have the following structures: (I); (II). Intermediates (V) are also claimed.